§866.3955. Human immunodeficiency virus (HIV) drug resistance genotyping assay using next generation sequencing technology. — Inbound Citations
21 C.F.R. § 866.3955
Statutory Authority
Cited by 9 regulations in release Current.
Citations to §866.3955(b)(3)(i)
-
(4) Premarket notification submissions must include the information in paragraphs (b)(3)(i) through (ix) of this section.
Citations to §866.3955(b)(3)(ii)
-
(4) Premarket notification submissions must include the information in paragraphs (b)(3)(i) through (ix) of this section.
Citations to §866.3955(b)(3)(iii)
-
(4) Premarket notification submissions must include the information in paragraphs (b)(3)(i) through (ix) of this section.
Citations to §866.3955(b)(3)(iv)
-
(4) Premarket notification submissions must include the information in paragraphs (b)(3)(i) through (ix) of this section.
Citations to §866.3955(b)(3)(ix)
-
(4) Premarket notification submissions must include the information in paragraphs (b)(3)(i) through (ix) of this section.
Citations to §866.3955(b)(3)(v)
-
(4) Premarket notification submissions must include the information in paragraphs (b)(3)(i) through (ix) of this section.
Citations to §866.3955(b)(3)(vi)
-
(4) Premarket notification submissions must include the information in paragraphs (b)(3)(i) through (ix) of this section.
Citations to §866.3955(b)(3)(vii)
-
(4) Premarket notification submissions must include the information in paragraphs (b)(3)(i) through (ix) of this section.
Citations to §866.3955(b)(3)(viii)
-
(4) Premarket notification submissions must include the information in paragraphs (b)(3)(i) through (ix) of this section.